Literature DB >> 7044264

Selective antimetastatic drugs (review).

T Giraldi, G Sava.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 7044264

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


× No keyword cloud information.
  5 in total

1.  Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy.

Authors:  Suzanne Leijen; Sjaak A Burgers; Paul Baas; Dick Pluim; Matthijs Tibben; Erik van Werkhoven; Enzo Alessio; Gianni Sava; Jos H Beijnen; Jan H M Schellens
Journal:  Invest New Drugs       Date:  2014-10-25       Impact factor: 3.850

2.  Changes in the tumorigenic and metastatic properties of murine melanoma cells treated with a triazene derivative.

Authors:  M Allegrucci; P Fuschiotti; P Puccetti; L Romani; M C Fioretti
Journal:  Clin Exp Metastasis       Date:  1989 May-Jun       Impact factor: 5.150

3.  Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex.

Authors:  G Sava; I Capozzi; K Clerici; G Gagliardi; E Alessio; G Mestroni
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

4.  Chemotherapeutic sensitivity of liver metastases from intrasplenically-growing Lewis lung tumor.

Authors:  K Pál; L Kopper; K Lapis
Journal:  Clin Exp Metastasis       Date:  1983 Oct-Dec       Impact factor: 5.150

5.  Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice.

Authors:  G Sava; T Giraldi; L Perissin; S Zorzet; G Decorti
Journal:  Clin Exp Metastasis       Date:  1987 Jan-Mar       Impact factor: 5.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.